Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus.

Abstract

Microglia play a major role in the innate immune responses of the CNS and the pathogenesis of Alzheimer’s disease (AD). However, the contribution of nonparenchymal or brain‑infiltrated myeloid cells to disease progression remains to be demonstrated. Here, we show that monocyte‑derived cells (MDC) invade brain parenchyma in advanced stages of AD continuum using transcriptional analysis and immunohistochemical characterization in post‑mortem human hippocampus. Our findings demonstrated that a high proportion (60%) of demented Braak V–VI individuals was associated with up‑regulation of genes rarely expressed by microglial cells and abundant in monocytes, among which stands the membrane‑bound scavenger receptor for haptoglobin/hemoglobin complexes or Cd163. These Cd163‑positive MDC invaded the hippocampal parenchyma, acquired a microgliallike morphology, and were located in close proximity to blood vessels. Moreover, and most interesting, these invading monocytes infiltrated the nearby amyloid plaques contributing to plaque‑associated myeloid cell heterogeneity. However, in aged‑matched control individuals with hippocampal amyloid pathology, no signs of MDC brain infiltration or plaque invasion were found. Our data suggest a clear association between MDC infiltration and endothelial activation which in turn may contribute to damage of the blood brain barrier integrity. The recruitment of monocytes could be a consequence rather than the cause of the severity of the disease. Whether monocyte infiltration is beneficial or detrimental to AD pathology remains to be fully elucidated. These findings open the opportunity to design targeted therapies, not only for microglia but also for the peripheral immune cell population to modulate amyloid pathology and provide a better understanding of the immunological mechanisms underlying the progression of AD.